Please enable JavaScript to continue using this application.

Compare $ARWR vs $CAI | Chartloom

Compare

$ARWR vs $CAI

Arrowhead Pharmaceuticals Inc · Caris Life Sciences Inc

ARWR

Arrowhead Pharmaceuticals Inc

CAI

Caris Life Sciences Inc

Compare $ARWR vs $CAI

Comparing Arrowhead Pharmaceuticals Inc and Caris Life Sciences Inc

ARWRArrowhead Pharmaceuticals Inc

CAICaris Life Sciences Inc

ARWRArrowhead Pharmaceuticals Inc

Market cap

$8.84B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

43.85x

Rev growth (TTM)

16.8%

YTD performance

-7.4%

52W performance

69.9%

FCF yield

-0.8%

CAICaris Life Sciences Inc

Market cap

$8.40B

P/E (TTM)

79.91x

Forward P/E (NTM)

101.64x

Forward P/S (NTM)

7.48x

Rev growth (TTM)

24.4%

YTD performance

10.1%

52W performance

-9.9%

FCF yield

1.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ARWR

CAI

Detailed metrics comparison

ARWR

Arrowhead Pharmaceuticals Inc

CAI

Caris Life Sciences Inc

Market Cap

ARWR$8.84B

CAI$8.40B

Enterprise Value

ARWR$10.04B

CAI$8.10B

Price

ARWR$62.75

CAI$29.70

P/E Ratio

ARWRN/A

CAI79.91x

P/S Ratio

ARWR13.20x

CAI8.48x

EV/Sales

ARWR15.00x

CAI8.18x

EV/EBITDA

ARWR31.55x

CAI45.95x

P/B Ratio

ARWR19.48x

CAI13.52x

P/FCF Ratio

ARWRN/A

CAI67.73x

EV/FCF

ARWR-133.73x

CAI65.33x

PEG Ratio

ARWRN/A

CAIN/A

Forward P/E (NTM)

ARWRN/A

CAI101.64x

Forward P/S (NTM)

ARWR43.85x

CAI7.48x

Revenue (TTM)

ARWR$669M

CAI$990M

Revenue Growth (YoY)

ARWR16.8%

CAI24.4%

Forward Rev Growth

ARWR131.3%

CAI18.2%

Gross Margin (TTM)

ARWR0.0%

CAI69.7%

Operating Margin (TTM)

ARWR0.0%

CAI12.7%

EBITDA Margin (TTM)

ARWR-30.0%

CAI17.6%

Net Margin (TTM)

ARWR-47.8%

CAI10.6%

FCF Margin (TTM)

ARWR-11.2%

CAI12.5%

Net Income (TTM)

ARWR$-320M

CAI$105M

FCF (TTM)

ARWR$-75M

CAI$124M

EPS (TTM)

ARWR-$2.23

CAI$0.37

ROE (TTM)

ARWR-6054.0%

CAI18.8%

ROA (TTM)

ARWR-1737.0%

CAI9.3%

ROIC (TTM)

ARWR-2193.0%

CAI11.2%

Cash

ARWR$51M

CAI$691M

Debt

ARWR$1.26B

CAI$393M

Net Cash/Debt

ARWR$-1.21B

CAI$298M

Current Ratio (TTM)

ARWR5.90x

CAI5.53x

Quick Ratio (TTM)

ARWR5.81x

CAI4.78x

Debt/Equity (TTM)

ARWR2.70x

CAI0.66x

Debt/Assets (TTM)

ARWR0.0%

CAI0.0%

Interest Coverage (TTM)

ARWRN/A

CAIN/A

Net Debt/EBITDA (TTM)

ARWR0.00x

CAI0.00x

Beta

ARWR1.34

CAI0.40

52W Performance

ARWR69.9%

CAI-9.9%

YTD Performance

ARWR-7.4%

CAI10.1%

% from 52W High

ARWR-34.3%

CAI-11.7%

% from 52W Low

ARWR81.3%

CAI109.3%

Asset Turnover (TTM)

ARWR0.36x

CAI0.88x

FCF Yield (TTM)

ARWR-0.8%

CAI1.5%

Earnings Yield (TTM)

ARWR-3.6%

CAI1.3%

Dividend Yield (TTM)

ARWRN/A

CAIN/A

Rule of 40

ARWR5.6

CAI37.0

EV/GP/RG

ARWRN/A

CAI0.86

Ticker research

View ARWR research View CAI research

Metric	ARWR Arrowhead Pharmaceuticals Inc	CAI Caris Life Sciences Inc
Market & Valuation
Market Cap	$8.84B	$8.40B
Enterprise Value	$10.04B	$8.10B
Price	$62.75	$29.70
P/E Ratio	N/A	79.91x
P/S Ratio	13.20x	8.48x
EV/Sales	15.00x	8.18x
EV/EBITDA	31.55x	45.95x
P/B Ratio	19.48x	13.52x
P/FCF Ratio	N/A	67.73x
EV/FCF	-133.73x	65.33x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	101.64x
Forward P/S (NTM)	43.85x	7.48x
Revenue & Growth
Revenue (TTM)	$669M	$990M
Revenue Growth (YoY)	16.8%	24.4%
Forward Rev Growth	131.3%	18.2%
Profitability
Gross Margin (TTM)	0.0%	69.7%
Operating Margin (TTM)	0.0%	12.7%
EBITDA Margin (TTM)	-30.0%	17.6%
Net Margin (TTM)	-47.8%	10.6%
FCF Margin (TTM)	-11.2%	12.5%
Net Income (TTM)	$-320M	$105M
FCF (TTM)	$-75M	$124M
EPS (TTM)	-$2.23	$0.37
ROE (TTM)	-6054.0%	18.8%
ROA (TTM)	-1737.0%	9.3%
ROIC (TTM)	-2193.0%	11.2%
Financial Health
Cash	$51M	$691M
Debt	$1.26B	$393M
Net Cash/Debt	$-1.21B	$298M
Current Ratio (TTM)	5.90x	5.53x
Quick Ratio (TTM)	5.81x	4.78x
Debt/Equity (TTM)	2.70x	0.66x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.34	0.40
52W Performance	69.9%	-9.9%
YTD Performance	-7.4%	10.1%
% from 52W High	-34.3%	-11.7%
% from 52W Low	81.3%	109.3%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.88x
FCF Yield (TTM)	-0.8%	1.5%
Earnings Yield (TTM)	-3.6%	1.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5.6	37.0
EV/GP/RG	N/A	0.86
Ticker research	View ARWR research	View CAI research

Valuation

P/E Ratio

CAI

79.91x

P/S Ratio

CAI

8.48x

ARWR

13.20x

EV/FCF

ARWR

-133.73x

CAI

65.33x

Growth & revenue

Revenue Growth TTM

CAI

24.4%

ARWR

16.8%

Forward Revenue Growth

ARWR

131.3%

CAI

18.2%

Profitability & performance

Gross Margin

CAI

69.7%

ARWR

0.0%

ROE

CAI

18.8%

ARWR

-6054.0%

FCF Yield %

CAI

1.5%

ARWR

-0.8%

52-Week Performance

ARWR

69.9%

CAI

-9.9%

Detailed metrics comparison

ARWR

Arrowhead Pharmaceuticals Inc

CAI

Caris Life Sciences Inc

Market Cap

ARWR$8.84B

CAI$8.40B

Enterprise Value

ARWR$10.04B

CAI$8.10B

Price

ARWR$62.75

CAI$29.70

P/E Ratio

ARWRN/A

CAI79.91x

P/S Ratio

ARWR13.20x

CAI8.48x

EV/Sales

ARWR15.00x

CAI8.18x

EV/EBITDA

ARWR31.55x

CAI45.95x

P/B Ratio

ARWR19.48x

CAI13.52x

P/FCF Ratio

ARWRN/A

CAI67.73x

EV/FCF

ARWR-133.73x

CAI65.33x

PEG Ratio

ARWRN/A

CAIN/A

Forward P/E (NTM)

ARWRN/A

CAI101.64x

Forward P/S (NTM)

ARWR43.85x

CAI7.48x

Revenue (TTM)

ARWR$669M

CAI$990M

Revenue Growth (YoY)

ARWR16.8%

CAI24.4%

Forward Rev Growth

ARWR131.3%

CAI18.2%

Gross Margin (TTM)

ARWR0.0%

CAI69.7%

Operating Margin (TTM)

ARWR0.0%

CAI12.7%

EBITDA Margin (TTM)

ARWR-30.0%

CAI17.6%

Net Margin (TTM)

ARWR-47.8%

CAI10.6%

FCF Margin (TTM)

ARWR-11.2%

CAI12.5%

Net Income (TTM)

ARWR$-320M

CAI$105M

FCF (TTM)

ARWR$-75M

CAI$124M

EPS (TTM)

ARWR-$2.23

CAI$0.37

ROE (TTM)

ARWR-6054.0%

CAI18.8%

ROA (TTM)

ARWR-1737.0%

CAI9.3%

ROIC (TTM)

ARWR-2193.0%

CAI11.2%

Cash

ARWR$51M

CAI$691M

Debt

ARWR$1.26B

CAI$393M

Net Cash/Debt

ARWR$-1.21B

CAI$298M

Current Ratio (TTM)

ARWR5.90x

CAI5.53x

Quick Ratio (TTM)

ARWR5.81x

CAI4.78x

Debt/Equity (TTM)

ARWR2.70x

CAI0.66x

Debt/Assets (TTM)

ARWR0.0%

CAI0.0%

Interest Coverage (TTM)

ARWRN/A

CAIN/A

Net Debt/EBITDA (TTM)

ARWR0.00x

CAI0.00x

Beta

ARWR1.34

CAI0.40

52W Performance

ARWR69.9%

CAI-9.9%

YTD Performance

ARWR-7.4%

CAI10.1%

% from 52W High

ARWR-34.3%

CAI-11.7%

% from 52W Low

ARWR81.3%

CAI109.3%

Asset Turnover (TTM)

ARWR0.36x

CAI0.88x

FCF Yield (TTM)

ARWR-0.8%

CAI1.5%

Earnings Yield (TTM)

ARWR-3.6%

CAI1.3%

Dividend Yield (TTM)

ARWRN/A

CAIN/A

Rule of 40

ARWR5.6

CAI37.0

EV/GP/RG

ARWRN/A

CAI0.86

Ticker research

View ARWR research View CAI research

Metric	ARWR Arrowhead Pharmaceuticals Inc	CAI Caris Life Sciences Inc
Market & Valuation
Market Cap	$8.84B	$8.40B
Enterprise Value	$10.04B	$8.10B
Price	$62.75	$29.70
P/E Ratio	N/A	79.91x
P/S Ratio	13.20x	8.48x
EV/Sales	15.00x	8.18x
EV/EBITDA	31.55x	45.95x
P/B Ratio	19.48x	13.52x
P/FCF Ratio	N/A	67.73x
EV/FCF	-133.73x	65.33x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	101.64x
Forward P/S (NTM)	43.85x	7.48x
Revenue & Growth
Revenue (TTM)	$669M	$990M
Revenue Growth (YoY)	16.8%	24.4%
Forward Rev Growth	131.3%	18.2%
Profitability
Gross Margin (TTM)	0.0%	69.7%
Operating Margin (TTM)	0.0%	12.7%
EBITDA Margin (TTM)	-30.0%	17.6%
Net Margin (TTM)	-47.8%	10.6%
FCF Margin (TTM)	-11.2%	12.5%
Net Income (TTM)	$-320M	$105M
FCF (TTM)	$-75M	$124M
EPS (TTM)	-$2.23	$0.37
ROE (TTM)	-6054.0%	18.8%
ROA (TTM)	-1737.0%	9.3%
ROIC (TTM)	-2193.0%	11.2%
Financial Health
Cash	$51M	$691M
Debt	$1.26B	$393M
Net Cash/Debt	$-1.21B	$298M
Current Ratio (TTM)	5.90x	5.53x
Quick Ratio (TTM)	5.81x	4.78x
Debt/Equity (TTM)	2.70x	0.66x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.34	0.40
52W Performance	69.9%	-9.9%
YTD Performance	-7.4%	10.1%
% from 52W High	-34.3%	-11.7%
% from 52W Low	81.3%	109.3%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.88x
FCF Yield (TTM)	-0.8%	1.5%
Earnings Yield (TTM)	-3.6%	1.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5.6	37.0
EV/GP/RG	N/A	0.86
Ticker research	View ARWR research	View CAI research